Glycoconjugates

DBCAT000084Pharmacologic class

Carbohydrates covalently linked to a nonsugar moiety (lipids or proteins). The major glycoconjugates are glycoproteins, glycopeptides, peptidoglycans, glycolipids, and lipopolysaccharides. A DrugBank category of 79 drugs. 30 of them are approved.

Drugs: ABX-196
Adecatumumab
Alefacept
Alpha-1-proteinase inhibitor
Alpha-galactosylceramide
Anatumomab mafenatox
Avidin
Balhimycin
Balugrastim
Bleomycin
Bleomycin A2
Bleomycin A6
Cefilavancin
Ceramide AP
Ceramide NG
Ceramide NP
Conestat alfa
Dalbavancin
Darbepoetin alfa
Defoslimod
Drotrecogin alfa
EDI-200
Efbemalenograstim alfa
Eflapegrastim
Epoetin beta
and 54 more with a free account

What you can answer from here — as of August 24, 2016

79DrugsEach linked to its full drug card

90Drug targetsEvery drug–target pair in the class, with bond type

3,592Marketed productsAcross the regions we cover, with dosage forms and routes

15Routes of administrationHow the drugs in this class are given

Which targets do Glycoconjugates share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account